Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
Completed · Phase 1
Conditions studied: Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Breast Cancer
In brief
The main purpose of this study is to see if the study drug, PTK787, is safe and to find the highest dose that can be given safely without causing serious side effects.
Key facts
- Study ID
- NCT00268918
- Run by
- Dana-Farber Cancer Institute
- People needed
- 24
- Starts
- 2005-09-01
- Expected to finish
- 2011-01-01
- Last updated by the study team
- 2018-07-27
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Recurrent gynecological cancers or metastatic breast cancer. Initial diagnosis must be confirmed histologically.
- Measurable disease or nonmeasurable disease
- Age > 18 years
- ECOG performance 0,1,2
- 4 weeks or greater since major surgery, 3 weeks or greater since chemotherapy
- Certain lab values
- Negative for proteinuria
You may not qualify if…
- Four or more treatment regimens
- History or presence of uncontrolled CNS disease
- Prior biologic or immunotherapies less than 3 weeks prior to registration
- Prior full field radiotherapy less than 4 weeks or limited field radiotherapy less than 2 weeks prior to registration
- Prior therapy with anti-VEGF agents
- Peripheral neuropathy with functional impairment > CTC grade 2
- Pregnant or breast feeding
- Concurrent severe and/or uncontrolled medical condition
- Chronic renal disease
- Acute or chronic liver disease
- Impairment of gastrointestinal function or GI disease
- Confirmed diagnosis of HIV infection are excluded at the investigators discretion
- Therapeutic warfarin sodium or similar oral anticoagulants that are metabolized by the cytochrome p450 system.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.